Journal ArticleJid Innovations · November 1, 2025
The management of dermatologic immune–related adverse events (D-irAEs) remains inconsistent owing to variability in treatment responses and a lack of standardized guidelines. Establishing evidence-based recommendations is critical to improving patient outc ...
Full textCite
Journal ArticleRheumatology (Oxford) · December 1, 2024
OBJECTIVES: Cutaneous dermatomyositis (DM) is often refractory to multiple medications. Repository corticotropin injection (RCI) is FDA-approved for DM, but little is known about its efficacy and safety for treating cutaneous DM. We conducted a prospective ...
Full textLink to itemCite
Journal ArticleDermatology · 2024
INTRODUCTION: Pyoderma gangrenosum (PG) is a rare ulcerative skin condition with an increased risk of mortality compared to the general population. The causes of this increased risk are not well understood. Misdiagnosis is common in PG, and many studies ar ...
Full textLink to itemCite
Journal ArticleCleve Clin J Med · January 3, 2023
Cutaneous abnormalities were among the first clinical findings reported in patients infected with SARS-CoV-2 at the onset of the COVID-19 pandemic, but the significance was initially unclear. Correlations have since been drawn between many of these cutaneo ...
Full textLink to itemCite
Journal ArticleCleve Clin J Med · March 1, 2022
Cutaneous findings can be clues to diagnosis and infection severity in viral illnesses, including COVID-19. The authors provide an update on the diagnostic and prognostic value of the 5 most common cutaneous abnormalities associated with COVID-19 in adult ...
Full textLink to itemCite
Journal ArticleAnnals of Medicine and Surgery · September 1, 2020
Introduction: Necrotizing neutrophilic dermatoses can clinically resemble necrotizing fasciitis and therefore pose a diagnostic and therapeutic challenge. Given their similar presentations, misdiagnosis and inappropriate or delayed treatments are possible. ...
Full textCite